Warner-Lambert Company
Patent Owner
Stats
- 227 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 17, 2017 most recent publication
Details
- 227 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 37,091 Total Citation Count
- Sep 30, 1971 Earliest Filing
- 1,897 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9790177 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)Oct 04, 16Oct 17, 17[C07D]
9481647 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-Phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)Oct 27, 15Nov 01, 16[C07D]
9199932 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)Oct 22, 14Dec 01, 15[C07D]
8895758 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-Dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)Sep 09, 13Nov 25, 14[C07D]
8648109 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesiumJan 22, 13Feb 11, 14[C07D, A61P]
8563750 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)Aug 22, 11Oct 22, 13[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0102,675 Solid Pharmaceutical Compositions Containing PregabalinAbandonedDec 06, 12Apr 25, 13[A61K]
2012/0232,149 SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALINAbandonedMay 16, 12Sep 13, 12[A61K, A61P]
2012/0029,081 Solid Pharmaceutical Compositions Containing PregabalinAbandonedOct 06, 11Feb 02, 12[A61K, A61P]
2011/0144,181 Pharmaceutical Compositions of Amorphous Atorvasta and Process for Preparing SameAbandonedFeb 24, 11Jun 16, 11[A61K]
2010/0215,654 Methods of treating Osteoarthritis with IL-6 AntagonistsAbandonedMar 16, 10Aug 26, 10[A61K, A61P]
2009/0227,587 Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K)AbandonedOct 19, 04Sep 10, 09[A61K, C07D]
2009/0221,546 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADEAbandonedJun 16, 08Sep 03, 09[A61K, C07D, A61P]
2009/0170,852 NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORSAbandonedOct 08, 08Jul 02, 09[A61K, C07D]
7501425 Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines as inhibitors of cellular proliferationExpiredMay 10, 99Mar 10, 09[A61K, C07D]
2009/0029,995 HETERO BIARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORSAbandonedNov 29, 06Jan 29, 09[A61K, C07D, A61P]
2008/0293,715 Therapeutic Pyrazolo[3,4-b]Pyridines and IndazolesAbandonedAug 04, 08Nov 27, 08[A61K, C07D]
2008/0287,674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation CascadeAbandonedJun 26, 08Nov 20, 08[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
